Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_4

25%

Ph phase_1

25%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 3Large-scale testing

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (33.3%)

Phase 31 (33.3%)

Phase 41 (33.3%)

Trials by Status

terminated125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completed

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

NCT02600741

completedphase_4

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

NCT02307396

terminatedphase_3

Pharmacovigilance in Gerontopsychiatric Patients

NCT02374567

completedphase_1

Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia

NCT02096289

Clinical Trials (4)

Showing 4 of 4 trials

NCT02600741

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

Completed

NCT02307396Phase 4

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

Completed

NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated

NCT02096289Phase 1

Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4